Inventaire - your friends and communities are your best library

Cerebrospinal fluid profile of amyloid beta peptides in patients with Alzheimer's disease determined by protein biochip technology

Author

Andreas Papassotiropoulos

published in: Neurodegenerative Diseases

date of publication: 2004-01-01

main subject: Alzheimer's disease, cerebrospinal fluid

Bibliographic databases:

Cites articles 19

Date

Title

Authors

1984-07

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease,Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
1993-05-11

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease
1994-07-01

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).
1995-03-01

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).
1996-12-01

The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry
1998-07-01

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.
1998-07-01

Detection and quantitation of cellularly derived amyloid β peptides by immunoprecipitation‐HPLC‐MS
1999-11-01

Semiquantitative analysis of amyloid beta peptides using a combination of immunoprecipitation and matrix-assisted laser desorption ionization/ time-of-flight-mass spectrometry
2000-07-01

Diagnostic approaches to Alzheimer's disease
2000-02-01

Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease.
2000-01-01

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.
2000-01-01

Age-dependent change in the levels of Abeta40 and Abeta42 in cerebrospinal fluid from control subjects, and a decrease in the ratio of Abeta42 to Abeta40 level in cerebrospinal fluid from Alzheimer's disease patients
2000-09-01

The use of seldi proteinchip arrays to monitor production of Alzheimer's betaamyloid in transfected cells.
2001-03-01

The levels of cerebrospinal fluid Abeta40 and Abeta42(43) are regulated age-dependently.
2001-11-01

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity
2001-11-01

An inflammatory drug prospect
2002-05-01

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation

, ,
2002-08-01

Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity
2003-01-01

The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide

, , , , , ,

Article -

Welcome to inventaire

The library of your friends and communities

Learn more